Image

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Investigational Medication for Pancreatic Ductal Adenocarcinoma

Recruiting
18 years and older
All
Phase 0
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates pancreatic ductal adenocarcinoma. The purpose of this study is to evaluate the effects of an investigational medication on tumor cells in patients with this condition.

The study focuses on assessing the safety and how well the investigational medication works in the body. It also looks into finding markers that might predict how patients respond to the treatment.

  • Who can participate: Adults 18 years and older with pancreatic ductal adenocarcinoma can participate. Participants must have a lesion that can be biopsied and agree to at least two biopsies.
  • Study details: Participants will receive the investigational medication intravenously. They will also have imaging tests, tumor biopsies, and blood samples taken.
Print
Study details
    Locally Advanced Pancreatic Ductal Adenocarcinoma
    Metastatic Pancreatic Ductal Adenocarcinoma
    Stage II Pancreatic Cancer AJCC v8
    Stage III Pancreatic Cancer AJCC v8
    Stage IV Pancreatic Cancer AJCC v8

NCT07089940

OHSU Knight Cancer Institute

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.